The protective miRNAs, hsa-miR-125a-5p and hsa-miR-125b-5p, were identified in this study as targeting 73 genes involved in the HIF-1 signaling pathway, Hepatitis C, and resistance to EGFR tyrosine kinase inhibitors. This evidence concerns the gene EGFR and hepatitis C virus infection.